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Abstract
Background: Virtual or in silico ligand screening combined with other computational methods is
one of the most promising methods to search for new lead compounds, thereby greatly assisting
the drug discovery process. Despite considerable progresses m a d e  i n  v i r t u a l  s c r e e n i n g
methodologies, available computer programs do not easily address problems such as: structural
optimization of compounds in a screening library, receptor flexibility/induced-fit, and accurate
prediction of protein-ligand interactions. It has been shown that structural optimization of chemical
compounds and that post-docking optimization in multi-step structure-based virtual screening
approaches help to further improve the overall efficiency of the methods. To address some of these
points, we developed the program AMMOS for refining both, the 3D structures of the small
molecules present in chemical libraries and the predicted receptor-ligand complexes through
allowing partial to full atom flexibility through molecular mechanics optimization.
Results: The program AMMOS carries out an automatic procedure that allows for the structural
refinement of compound collections and energy minimization of protein-ligand complexes using the
open source program AMMP. The performance of our package was evaluated by comparing the
structures of small chemical entities minimized by AMMOS with those minimized with the Tripos
and MMFF94s force fields. Next, AMMOS was used for full flexible minimization of protein-ligands
complexes obtained from a mutli-step virtual screening. Enrichment studies of the selected pre-
docked complexes containing 60% of the initially added inhibitors were carried out with or without
final AMMOS minimization on two protein targets having different binding pocket properties.
AMMOS was able to improve the enrichment after the pre-docking stage with 40 to 60% of the
initially added active compounds found in the top 3% to 5% of the entire compound collection.
Conclusion: The open source AMMOS program can be helpful in a broad range of in silico drug
design studies such as optimization of small molecules or energy minimization of pre-docked
protein-ligand complexes. Our enrichment study suggests that AMMOS, designed to minimize a
large number of ligands pre-docked in a protein target, can successfully be applied in a final post-
processing step and that it can take into account some receptor flexibility within the binding site
area.
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Background
Structure-based virtual ligand screening (SBVLS) allows to
investigate thousands or millions of molecules against a
biomolecular target [1,2], and as such it plays an increas-
ingly important role in modern drug discovery programs.
For example, numerous SBVLS methods employing dock-
ing and scoring have been developed to assist the discov-
ery of hit compounds and their optimization to leads [3-
5]. These methods orient and score small molecules in a
protein-binding site, searching for shape and chemical
complementarities. Many novel active compounds acting
on key therapeutic targets have been found through com-
bining SBVLS and in vitro screening experiments [5,6].
Despite the considerable progresses achieved these recent
years, several problems are still present in most of the cur-
rently available SBVLS packages. Among the most critical
is the flexibility of the receptors that frequently change
their conformations upon ligand binding. Several meth-
ods have been developed to attempt to take into consider-
ation receptor flexibility during docking/scoring [2,7-10],
however, this is still very challenging because the number
of conformations rises exponentially with the number of
rotatable bonds and the full sampling of all possible con-
formations is not feasible for a large number of protein-
ligand complexes.
Further the correct prediction of receptor-ligand binding
energies [11,12] and accurate ranking of the compounds
with respect to their estimated affinities to a target
remains highly challenging. Thus it is still difficult to dis-
criminate bioactive compounds from false positives
[13,14] despite recent efforts to improve enrichment via,
for instance, docking on different protein targets [15] or
through optimized or new scoring functions [12,16,17].
In addition, and among the many players that are impor-
tant in SBVLS computations, the quality of the screened
chemical libraries has also been shown to be important in
order to correctly predict the bound ligand-conformations
and for ranking [18,19]. Within this context, further
refinements and optimization of VLS docking-scoring
methods are needed.
Recently it has been suggested that post-docking optimi-
zation, either after conventional docking-scoring proce-
dures or after hierarchical VLS protocols [20-23] may help
to further improve both, the docking pose and the scor-
ing, and as such the overall efficiency of SBVLS experi-
ments. Recent examples of docked poses and enrichment
improvements after post-docking energy minimization
support this view [19,24-27].
In the present study, we propose a new open source pro-
gram, named AMMOS, which addresses some of the pre-
and post-processing problems associated with SBVLS
computations, through molecular mechanics (MM) mod-
eling. AMMOS executes an automatic procedure for: (1)
energy minimization of pre-docked protein-ligand com-
plexes allowing partial or full atom flexibility from both,
the ligand and the receptor sides and (2) structural opti-
mization of chemical compounds present in the screening
libraries prior to docking experiments. MM is currently a
very reliable approach to model protein-receptor interac-
tions in a physically realistic manner [26-28] since it can
account for local flexibility adjustments from both, the
protein and the ligand although conformational explora-
tion is not possible if large conformational changes occur.
It is indeed reasonable to apply such framework instead of
more computer demanding simulations (for instance
molecular dynamics) in large-scale applications involving
the handling of thousands of compounds. In conven-
tional MM studies, the bonded interactions include the
bonds, bond angles and dihedral terms while the non-
bonded interactions involve the van der Waals term repre-
sented by the Lennard-Jones (LJ) 6–12 potential, and elec-
trostatic interactions, often treated by Coulombic
potential computed between point charges centered on
relevant atoms. AMMOS proposes relatively fast energy
minimization by making use of the full-featured molecu-
lar mechanics program AMMP [28-31]. AMMP is available
upon GNU license and has been recently implemented in
the well-known OpenGL molecular modeling package
VEGA [32]. In particular, VEGA implements AMMP for
energy minimization with all the available optimization
methods. However, to the best of our knowledge, VEGA
can not minimize chemical libraries nor a large number of
pre-docked protein-ligand complexes. AMMP has several
advantages that make it relevant for the present applica-
tions such as: a fast multipole method for including all
atoms in the calculation of long-range potentials and
robust structural optimizers. AMMP has a flexible choice
of several bonded and non-bonded potentials and per-
mits analysis of individual energy terms. An additional
advantage of AMMP is that it allows straightforward intro-
duction of non-standard polymer linkages and non-
standard amino-acid residues as well as manipulation of
both small molecules and macromolecules including pro-
teins, nucleic acids and other polymers. Furthermore,
extensive benchmarking of AMMP has been performed
highlighting its accuracy in term of energy minimization
of proteins (i.e., the changes of atomic positions after
minimization have been shown to be within the range of
experimentally obtained variations in different crystal
forms [33] and the calculated protein-ligand interaction
energies have been successfully correlated with measured
ligand binding affinities [34]). Up to now, AMMP has
been successfully applied in numerous modeling studies
of proteins and protein-ligand complexes [28,29,34,35]
but it has not been used thus far for SBVLS computations
as numerous implementations would be necessary to
apply it automatically on thousands of small molecules,BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
Page 3 of 15
(page number not for citation purposes)
either present in a database or docked in a receptor bind-
ing site.
In this article we describe the development, implementa-
tion and evaluation of the AMMOS approach for auto-
matic energy minimization of protein-ligand complexes
or of small organic molecules. First energy minimization
with AMMOS was validated by refinement of a large
chemical library and by comparison of small molecule
optimizations with two well established force fields avail-
able in the package SYBYL [36]. The efficiency of AMMOS
for optimization of pre-docked protein-ligand complexes
was then examined through performing calculations on
two protein targets, namely estrogen receptor (ER) and
neuraminidase (NA). These two proteins were selected
because they are often used in SBVLS studies and because
their binding pockets display rather different physico-
chemical properties and geometries. We used a multi-step
SBVLS protocol to generate protein-ligand complexes.
Our first VLS stage employed a search for satisfactory
shape complementarity allowing rational reduction of the
size of the initial chemical library. The pre-docked com-
plexes subjected to AMMOS minimization were generated
via the second step involving flexible-ligand docking.
Finally we tested AMMOS as a final re-scoring engine on
the selected pre-docked protein-ligand complexes for
both, ER and NA. The obtained results are promising and
suggest that AMMOS can be successfully applied as a post-
processing tool to improve enrichment.
Methods
AMMP Molecular Mechanics
AMMOS makes use of the molecular simulation package
AMMP [30], a program that can easily be embedded in
other packages. AMMP allows to introduce standard or
non-standard polymer linkages (ensured by the program
PREAMMP included in the package AMMP), unusual lig-
ands or non-standard residues, as well as to complete par-
tial protein structures. AMMP incorporates a fast
multipole algorithm for the efficient calculation of long-
range forces thereby allowing evaluation of non-bonded
terms without the use of a cutoff radius and increasing the
speed, making calculations comparable to a standard
treatment with a 8–10 Å radius cutoff [28]. The AMMP
force field [28] is developed on the basis of the UFF poten-
tial set [37] and the AMBER partial charges [38]. The ini-
tial UFF set has been optimized for biological molecules
[28,29] in order to improve the agreement with experi-
mental geometry and spectral data. The first developed
AMMP force field was the set sp4 [28]. Lately, Bagossi and
co-authors [39] proposed the Modified Parameter Set for
AMMP (MOPSA) with improved generation of partial
charges for a wider range of compounds especially
adapted for modeling of macromolecules, where the elec-
trostatic parameters have been modified to achieve better
correlation with experimental dipole moments. MOPSA
parameter set has been merged with the AMMP parameter
set sp4 to generate the new standard force field set sp5 [39].
We tested several minimization methods as implemented
in AMMP. The steepest descent method [40] (first order)
that uses the first derivatives of the energy function to find
a local minimum, is available in AMMP, but this does not
necessarily produce the fastest convergence. The Poliak-
Ribeire Conjugate Gradient method (first order) [40], per-
forming a search along conjugate directions, can produce
generally faster convergence, is also implemented in
AMMP. For the second-order minimization methods, the
Broyden-Fletcher-Goldfarb-Shanno (BFGS) approach
[41] that belongs to the Quasi-Newton methods [40], is
available in AMMP. The non-derivative polytope simplex
method [41], as well as a genetic algorithm (GA) [42]
(evolutionary algorithms that perform directed random
search to find the optimal solution in a complex multidi-
mensional space) are also implemented in AMMP.
Energy minimization protocols
Energy minimization of small organic molecules using AMMOS
We explored both AMMP force fields, sp4 and sp5, on a set
of four small molecules structures generated by OMEGA
2.0 [43] (see Compound collections below). To speed-up
ligand parameterization, partial charges on ligand atoms
were assigned with the Gasteiger-Marsili method [44]
using the OpenBabel package [45]. The maximum
number of iterations was set to 5000. All calculations were
performed with a convergence value set to 0.01 or 0.02
kcal.mol-1.Å-1, and no essential differences were observed.
Thus, we chose 0.02 kcal.mol-1.Å-1 as convergence crite-
rion to reduce the computational time. The number of
iterations required to reach convergence with the conju-
gate gradient method (our results demonstrate that this
approach is the most efficient, see in the Results section)
varied between 300 and 1600 for different small com-
pounds. Therefore for further analysis, two protocols were
assessed: one protocol employing two subsequent steps of
500 iterations and one with 1000 iterations. The mini-
mized and initial structures were compared based on the
RMSD values between the non-hydrogen atoms using the
Superimpose option of the InsightII molecular modeling
package [46]. We should notice that small molecule min-
imization results depend on initial conformations and
this holds for any MM minimization engine. Problems
with possible biases due to the starting conformation and
exploration of other conformers can be circumvented by
the use of our multiconformer generator Multiconf-
DOCK [47] or of OMEGA prior to minimizing small mol-
ecules.BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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Energy minimization of small organic molecules using other force 
fields
Two MM minimization methods implemented in the pro-
gram SYBYL were applied on the same set of small mole-
cules in order to compare the minimization results
obtained with AMMOS. The initial structures of the four
small compounds, generated by OMEGA (see for details
Compound collections), were optimized by two force
fields: the Tripos force field (Tff) [36] and MMFF94s [48].
Tff minimization was performed with Gasteiger-Huckel
charges, and MMFF94s, with MMFF charges. For both
force fields, the following settings were used: distance-
dependent dielectric function; non-bonded cutoff 8.0 Å;
0.02 kcal.mol-1.Å-1 energy gradient convergence criterion;
simplex initial optimization. For comparison, several runs
were performed with 0.01 kcal.mol-1.Å-1 convergence and
no essential differences in the resulting geometries were
recorded. Two gradient methods were experimented:
Powell and conjugate gradient. Powell method [49]
belongs to the conjugate gradient family of minimization
methods. It is also more tolerant to inexact line searches.
As a result, it is faster than the conjugate gradient method
and is well-suited for a wide variety of problems [49]. The
number of iterations was set to 5000 for both methods, in
all cases however, the convergence was reached well
below this number. Because the Powell and conjugate gra-
dient results were quite similar, we report here only the
data obtained with the Powell method. The minimized
and initial structures were compared based on the RMSD
values between the non-hydrogen atoms using the Match
option in SYBYL. The calculations with SYBYL were per-
formed on a Silicon Graphics Octane 2 (R12000) running
under IRIX 6.5.
Docking and scoring protocol
The pre-docked protein-ligand complexes subjected to
energy minimization with AMMOS were generated via a
multi-step docking-scoring protocol with DOCK6 [50].
DOCK6 accomplishes a sphere-matching algorithm to fit
ligand atoms to spheres representing a negative image of
the receptor-binding site. We used the program DMS [51]
to compute the molecular surface of the receptor. The
overlapping spheres within a radius of 4 Å were generated
on the protein binding site surface using the program
SPHGEN [52]. Sphere clusters within 6 Å to a reference
ligand were retained for ER and 4 Å for NA (i.e., NA pos-
sesses a very open and flat binding site and it is important
to limit the search on the active site area for this kind of
target). The first docking step was carried out using rigid
body-docking with DOCK6 applying the MS-DOCK pro-
tocol [47] over a compound collection of 37970 mole-
cules (ADME/Tox filtered ChemBridge Diversity set)
present in a multi-conformer state without initial minimi-
zation with AMMOS (see Compound collections). This
stage assesses only shape complementarity and therefore,
multi-conformer structures for the small compounds are
needed in order to perform this fast "geometric" filtering
step. For the positioning of the ligand in the binding site,
we applied the faster manual match (see [50] and a maxi-
mum of 500 orientations). As mentioned above, in our
calculations, the scores measured only the steric comple-
mentarity by use of the contact scoring function that
counts the number of receptor-ligand contacts within a
4.5 Å distance from the ligand atoms. Each clash penal-
ized the score by 30. The allowed bump overlaps were
chosen to be 0.75 for NA and 0.50 for ER. These values
were selected according to our previous observations [47].
We have seen that for large and flat cavities binding rela-
tively small ligands like in the case of NA, a bump overlap
of 0.75 improves the enrichment after a rigid docking pro-
cedure. On the contrary, when large ligands fill well the
binding site, a bump overlap of 0.50 is preferable, a situa-
tion encountered with ER (see for details [47]).
Secondly, the retrieved non-minimized top ranked com-
pounds (30–50 % of the library containing at least 60% of
the actives) were directly re-docked using a flexible dock-
ing mode (i.e., flexibility from the ligand side) imple-
mented in DOCK6 and employing the incremental built
algorithm "anchor-first" [53] with our optimized parame-
ters to better handle ligand flexibility [47]. We used a max-
imum of 1000 orientations for the anchor fragment. To
speed-up the calculations, we set 50 configurations per
cycle for the growth of the ligands. We applied 20 simplex
minimization steps to each growth step. All docked mole-
cules were ranked using the standard DOCK score involv-
ing soft van der Waals and distance-dependent
electrostatic potentials. Finally for each ligand we saved
up to 10 best scored conformers with a RMSD of 0.8 Å for
subsequent minimization with AMMOS.
Dataset preparation
Compound collections
Energy minimization with AMMOS and the Tff and
MMFF94s force fields was carried out initially on 4 small
molecules, taken from several X-ray protein-ligand com-
plexes in the Protein Data Bank (PDB) [54], namely:
raloxifene (an inhibitor of estrogen receptor, PDB code
1err); 4-(n-acetylamino)-3- [n-(2-ethylbu-
tanoylamino)]benzoic acid (FDI) (an inhibitor of neu-
raminidase, PDB code 1b9s); thymidine (an inhibitor of
thymidine kinase, PDB code 1kim); thieno [3,2-b]pyrid-
ine-2-sulfonic acid [2-oxo-1-(1h-pyrrolo[2,3-c]pyridin-2-
ylmethyl)- pyrrolidin-3-yl]-amide (PR2) (an inhibitor of
coagulation factor X, PDB code 1f0r).
To test the performance of AMMOS on a large number of
small organic molecules we used the ChemBridge diver-
sity set [55]. Our decoy library contained 37970 mole-
cules after ADME/Tox filtering with the program FilterBMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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1.0.2 [43]. We merged 20 known active compounds for
ER and NA (with activities ranging from micromolar to
nanomolar) and a number of rotatable bonds ranging
from 4 to15) to the decoy collection. Some of the active
compounds were taken from the PDB protein-ligand
structures: 2 for ER (1err, 3ert; resolution 2.60 Å, 1.90 Å,
respectively) and 10 for NA (1inf, 1inv, 1ivb, 1vcj, 1b9s,
1b9t, 1b9v, 1a4g, 1f8b, 2qwk; resolution 2.35–2.50 Å).
When a ligand could not be extracted from the PDB, it was
rebuilt from the literature [56]. All these active inhibitors
were added to the decoy library, all in SMILES format. The
resulting chemical library was transformed in single 3D
conformer and saved in mol2 format using the program
OMEGA 2.0 [43]. The multiconformer states were then
generated by our program Multiconf-DOCK [47] applying
an energy window of 25 kcal.mol-1 and a diversity thresh-
old of 1 Å RMSD. A maximum of 50 conformers were gen-
erated for each molecule. These values represent an
appropriate balance between speed and accuracy accord-
ing to the recent studies [47,57].
Protein targets
The performance of AMMOS for post-processing of the
pre-docked protein-ligand complexes was validated on
two protein targets. We selected ER with a closed and
hydrophobic pocket and NA with an open and highly
polar binding site. These two proteins present a binding
site with very different degrees of burial (75.4% for ER and
30.5% for NA) and polarity (25% for ER and 65% for NA)
(see for details [20]). We took the co-crystallized struc-
tures with best resolution among all retrieved protein-lig-
and complexes (PDB code 3ert, resolution 1.90 Å for ER
and PDB code 1b9v, resolution 2.35 Å for NA). All bound
water molecules and crystallized ligands were removed
from the binding sites. Hydrogens were assigned using the
program InsightII [46].
Results
Algorithm of AMMOS
AMMOS drives a fully automatic procedure for minimiza-
tion of protein-ligand complexes in a situation where the
compounds are pre-docked in the binding site by any
docking engine. AMMOS parameters are optimized such
as to handle relatively large docked compound collec-
tions. Figure 1 illustrates all the different steps and
required inputs, preparation, minimization of protein-lig-
and complexes with different degrees of protein flexibil-
ity, as well as final ranking of the ligands according to the
minimized interaction energy between the ligands and
the receptor. Firstly, AMMOS employs the program
PREAMMP to convert the input protein and ligand files to
AMMP format. Next, AMMP autolink is run to search for
incomplete amino-acid residues and to finally link all the
residues after corrections. AMMOS allows users to select
one among five different solutions to handle protein-lig-
and complexes: from fully flexible minimization of the
whole protein-ligand complex (case 1) to a flexible ligand
in a rigid receptor (case 5) (see Fig. 1). In all situations, the
ligand atoms are free to move. Our minimization step
with AMMP applied on the protein-ligand complexes for
the selected protein flexibility case involves 2×500 itera-
tions with conjugate gradient optimization. The advances
user can select any minimization method available in
AMMP and specify the minimization parameters (i.e.
number of iterations, convergence etc.). Finally, all the
minimized conformers are scored by the AMMP mini-
mized interaction protein-ligand energy [28] and re-
ranked.
Implementation of AMMOS
The package AMMOS consists of several programs devel-
oped in C and Python, and makes use of the open source
programs AMMP and PREAMMP. One AMMOS routine
(written in C) ensures the transformation of the input files
(PDB for the protein and mol2 for the ligands) to a spe-
cific ammp format required by AMMP and at the end of
the process generate reversely, the protein in PDB format
and the small molecules in mol2 format. The automatiza-
tion of the procedure described in Figure 1 for a large
number of ligands in a single or multiple conformer state
is accomplished via a Python script. Five different cases
(scripts written in C) have been elaborated for the selec-
tion of the active/inactive atoms in the protein, while, in
all situations, the ligand atoms are flexible: case 1: all
atoms of the protein are active (a fully flexible minimiza-
tion); case 2: all atoms of the protein side chains are active;
case 3: all atoms of the protein inside a sphere around the
ligand are active; case 4: all atoms of the protein side
chains inside a sphere around the ligand are active; case 5:
the whole protein is rigid. After processing of the whole
pre-docked compound collection, the following results
are saved in a subdirectory named OUTPUT: (i) the coor-
dinates of all conformers after minimization, (ii) the coor-
dinates of the flexible part of the protein after
minimization, (iii) a file with warnings (if any), and (iv)
the interaction energy between the protein and the ligands
(external energy), the internal energies of the ligands or
the protein, and total energy (including internal and
external terms) before and after minimization. Finally a
re-ranking step takes place based on the computed exter-
nal energies of all minimized ligands. The method selects
the best conformer among the multiple ligand conform-
ers. The complete automatic procedure could be run for
either sp4 or sp5 force field. Because sp5 was not explicitly
available in AMMP, we created it using the extended and
parameterized list of atom types and electronegativity val-
ues available in reference [39].
Another application of AMMOS is for the minimization
of a large databank of chemical compounds in theBMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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Schematic diagram of the AMMOS procedure Figure 1
Schematic diagram of the AMMOS procedure. The arrows show the cycle of the automated procedure for a large 
number of ligands.
P Pr re ep pa ar ra at ti io on n   o of f   t th he e   p pr ro ot te ei in n   
   
x  running PREAMMP to prepare the 
protein in ammp format  
x  running AMMP autolink 
P Pr re ep pa ar ra at ti io on n   o of f   t th he e   l li ig ga an nd ds s   
   
x  creation of templates  
x  running PREAMMP to prepare the 
ligand in ammp format  
S Se el le ec ct ti io on n   o of f   t th he e   f fl le ex xi ib bi il li it ty y   c ca as se e   
   
x  Case 1: All protein and ligand atoms can move 
x  Case 2: Only the atoms of protein side chains and the ligand can move 
x  Case 3: Only the protein atoms inside a sphere around the ligand and the ligand atoms 
can move 
x  Case 4: Only the atoms of the protein side chains inside a sphere around the ligand and 
the ligand atoms can move 
x  Case 5: Only ligand atoms can move, while the whole protein is rigid 
M Mi in ni im mi iz za at ti io on n   f fo or r   t th he e   s se el le ec ct te ed d   c ca as se e   
F Fo or rm ma at t   c co on nv ve er rs si io on n   a an nd d   s sa av vi in ng g   o of f   t th he e   r re es su ul lt ts s   
   
x  convert ammp to pdb format and save protein in pdb format 
x  convert ammp to mol2 format and save small molecules in mol2 format 
x  save energy before and after minimization for further analysis 
I In np pu ut t   
x x    p pr ro ot te ei in n   i in n   p pd db b   
x x    l li ig ga an nd ds s   i in n   m mo ol l2 2   
Ranking of the protein-ligand complexes from the computed energy values 
Selection of the best conformer for each ligand 
 BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
Page 7 of 15
(page number not for citation purposes)
absence of a protein. The procedure follows the scheme
presented in Figure 1, and involves only the steps related
to the small molecules, namely preparation and minimi-
zation of small molecules and final re-conversion to mol2
format.
All VLS and AMMOS calculations were carried out on one
Mac Pro Quad-Core Xeon 3,0 GHz, 4Go RAM and on one
Xeon 3.0 GHz Linux workstation, 1.5 GB RAM. The aver-
age time for the minimization on an Apple workstation
was 0.3 sec for one small molecule and for one ligand
pose in a protein was 24 sec for case 5 (no protein flexibil-
ity is allowed), 44 sec for case 3 (all atoms of the protein
inside the sphere around the ligand are active), and 5 min
for case 1 (all protein and ligand atoms are active). Thus,
execution times when a large number of ligands should be
minimized with AMMOS can be very long. To speed-up
the calculations, AMMOS allows jobs to be ran in parallel
mode. The input mol2 file containing ligand molecules is
divided into chunks of smaller numbers of molecules.
During a parallel AMMOS run, each processor is assigned
one chunk of molecules at a time. Final ranking of the
complete databank containing the energy-minimized lig-
ands is then accomplished after merging of the different
chunks.
Testing of AMMOS
I. Energy minimization of small organic molecules
Prior to test the automatic procedure for minimization of
protein-ligand complexes, we first explored the ability of
AMMOS to minimize small organic molecules starting
from 3D structures generated by OMEGA. We compared
several minimization methods available in AMMP (see
AMMP Molecular Mechanics in the Methods section) and
further compared the results obtained with AMMP with
two other widely used force fields MMFF94s and Tff avail-
able in the SYBYL software.
Energy minimization of small molecules with AMMOS
The initial 3D structures of the four small molecules,
raloxifene, FDI, thymidine and PR2 (see in Methods,
Compound collections) generated by OMEGA were opti-
mized using AMMOS with the force fields sp4 and sp5.
Table 1 and Additional file 1 present the results for the
four molecules and the five different applied optimization
methods. For each method, the number of iterations
needed to find the local minimum and the energy of the
minimized structures are reported. As seen from Table 1,
sp4 and sp5 provided very similar results in terms of opti-
mized structural geometries. For PR2 and thymidine, low-
est energies of the minimized structures with both sp4 and
sp5 were achieved using the conjugate gradient method,
followed by BFGS and GA. Conjugate gradient and GA
gave the best results for raloxifene and FDI. For all tested
molecules, steepest descent and simplex search led to
minimized structures with higher energies. The above
comparison suggests that conjugate gradient and GA pro-
duced lowest energies, however GA was much slower due
to its stochastic nature. We also minimized structures con-
taining important internal clashes in order to assess the
robustness of the approach. After application of steepest
descent the minimized structures remained insufficiently
Table 1: Comparison of AMMP optimization methods for small molecules minimized with sp4 and sp5 force fields
Optimization methods
Compound Initial Energy Steepest descent Conjugate gradient BFGS Simplex GA
Niter Emin Niter Emin Niter Emin Niter Emin Niter Emin
raloxifene sp4 121.08 20 86.72 1600 66.71 1500 75.89 80 102.24 300 69.97
sp5 117.41 20 88.46 1000 71.65 1200 77.62 100 107.03 300 70.89
RMSD 0.01 1.23 0.05 0.14 0.42
FDI sp4 119.61 30 74.02 200 66.14 1200 64.38 10 268.07 300 48.95
sp5 116.89 30 75.48 300 67.94 1000 67.96 10 283.08 200 51.83
RMSD 0.01 0.12 0.02 0.14 1.14
thymidine sp4 99.64 30 64.82 400 60.52 500 61.17 20 114.81 300 61.40
sp5 95.78 20 68.49 200 64.29 1000 64.57 10 99.78 200 65.85
RMSD 0.01 0.09 0.03 0.06 0.63
PR2 sp4 156.55 50 -5.22 300 -14.57 700 -13.58 10 78.01 200 -5.77
sp5 155.04 50 1.11 300 -13.01 600 -11.77 20 72.18 200 -12.73
RMSD 0.07 0.02 0.01 0.02 0.61
The number of iterations needed to reach convergence (Niter) and the minimized energy (Emin in kcal/mol) and the RMSD values (in Å) between 
the optimized structures with sp4 and sp5 force fields are given.BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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optimized, while conjugate gradient succeeded to over-
come the clashes (results not shown). Although sp5 has
been reported to be an improved version of sp4 [39], in
our work sp4 minimized slightly better than sp5 in terms
of energy differences between the initial and minimized
structure, in particular for thymidine and raloxifene. Fol-
lowing the above observations, we chose conjugate gradi-
ent and sp4 as the minimization protocol for subsequent
assessment of AMMOS.
As seen from Table 1, the required number of iterations
for convergence (0.02 kcal.mol-1.Å-1 energy gradient con-
vergence criterion) with conjugate gradient varies between
200 and 1600 for different molecules. The four molecules
show different structural properties with various numbers
of rotatable bonds: 7 (raloxifene), 6 (FDI), 5 (PR2) and 2
(thymidine). Raloxifene and PR2 are larger than the other
two molecules with molecular weights of 473 and 453,
respectively. One can see from the figure reported in the
Additional File 1 that after 400 iterations with conjugate
gradient  the energy gradients of all molecules are very
close to the convergence criterion. Our additional tests
confirmed that using 1000 or 2× 500 iterations are an
acceptable compromise between geometric optimization
and speed. Thus, we accepted 2×500 iterations as an
appropriate number of steps for the automatic AMMOS
procedure aiming at minimizing thousands of small
organic molecules or of protein-ligand complexes (i.e.,
users can change these values if needed).
Further, we examined 4 different potential functions for
non-bonded interactions as implemented and named in
AMMP: 1) nonbon – involving point atom electrostatics; 2)
screen  – 1s distributed charge electrostatics; 3) debye  –
Debye screened potentials and 4) shadow  – 4-D non-
bonded for embedding. Because compared to the nonbon
potential, no significant differences were found with the
debye, screen and shadow modes and since they considera-
bly increase the lengths of the calculations, we selected the
nonbon potential for further evaluation of AMMOS (users
can employ the debye or shadow options scripts to account
for screening solvent effects).
Energy minimization of small molecules with other force fields
The results achieved after application of AMMOS minimi-
zation with conjugate gradient with 2× 500 iterations and
sp4 (this protocol is employed by the automatic procedure
for a large number of molecules) were compared with two
other force fields – MMFF94s and Tff applied on the same
four small molecules starting from 3D initial structures
generated by OMEGA. Similar results in terms of energies
and structural geometries were obtained with Powell and
conjugate gradient methods when one of the MMFF94s
and Tff force fields were used. Therefore only the results
with the method of Powell for both force fields MMFF94s
and Tff are reported here. Table 2 shows the energies of
the initial (Eini) and minimized (Emin) structures,
obtained with AMMOS, MMFF94s and Tff, as well as the
energy differences (ΔE) between the initial and mini-
mized structures. Although energy values obtained by dif-
ferent force fields are not directly comparable, the
differences between the energies of the initial and mini-
mized conformations can be indicative of the optimiza-
tion performance to search for the local minimum. As
seen from Table 2, generally there is a correlation between
ΔE values in AMMOS and the other force fields, thus con-
firming that AMMOS is able to remove ligand energy
strains.
Table 3A reports the RMSD values (all heavy atoms)
between the initial and optimized structures for the four
small molecules with the three force fields. When compar-
ing the RMSD values between the optimized and initial
structures similar results are observed between AMMOS
and MMFF94s, as could also be seen in Figure 2 which
represents the superimposition (all heavy atoms) of the
structures minimized by AMMP, MMFF94s and Tff. In
conclusion, the results obtained after minimization with
AMMOS are close to those obtained by other force fields.
A widely accepted quality measure for the predicted con-
Table 2: Energy minimization with the AMMP sp4, MMFF94s and Tff force fields
Compound AMMOS, sp4 MMFF94s Tff
Eini Emin ΔEE ini Emin ΔEE ini Emin ΔE
raloxifene 121.08 69.82 51.26 100.49 86.18 14.31 61.27 16.42 44.85
FDI 119.61 66.14 53.47 32.41 23.81 8.60 59.79 -1.03 60.82
thymidine 99.64 60.52 39.12 -40.41 -58.83 18.42 22.7 -1.58 24.28
PR2 156.55 -14.57 171.12 19.59 -43.31 62.90 146.95 10.27 136.68
Energies of the initial (Eini) and optimized (Emin) structures are given in kcal/mol.BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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formations of small molecules is the RMSD from struc-
tures extracted from crystal protein-ligand complexes
[57,58] despite the fact that the experimental structure
does not necessarily correspond to the lowest-energy con-
formation [58-60]. The RMSD values between our mini-
mized and X-ray structures are given in Table 3B. The
relatively low RMSD values between the optimized and X-
ray structures suggest that AMMOS produces reasonable
and reliable small compound structural geometries.
Energy minimizations of a large chemical library with AMMOS
The AMMOS procedure for minimization of small com-
pounds was applied to a chemical library of 37970 single
conformer molecules (see Methods, Compound collec-
tions). Figure 3A shows that the differences (ΔE) between
the energies of the AMMOS minimized and initial struc-
tures generated by OMEGA can be up to around 200
kcal.mol-1. Figure 3B shows in a more illustrative way the
ΔE distribution in the compounds databank: for 76% of
the molecules ΔE is below 50 kcal/mol, and only 4% of
the compounds show ΔE values > 100 kcal/mol. It should
be noted, that AMMOS succeeded to minimize molecules
with very high initial energies. The AMMOS minimization
improves the geometries thus making the optimized struc-
tures more appropriate for subsequent docking and scor-
ing. It is interesting to note that we did not succeed to
optimize several structures presenting severe internal
clashes and thus very high energies with the other minimi-
zation protocols like, for instance, steepest descend, at
Energy minimization results for a chemical library of 37970  small organic molecules Figure 3
Energy minimization results for a chemical library of 
37970 small organic molecules. A. Scatter-plot of the 
energy differences ΔE in kcal/mol between the AMMOS min-
imized and initial structures; B. Pieplot of the ΔE distribution.
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Table 3: RMSD values (in Å) obtained after matching the 
optimized and initial structures (A) and the optimized and X-ray 
structures (B)
A AMMOS MMFF94s Tff
raloxifene 0.80 0.84 1.34
FDI 0.14 0.49 1.13
thymidine 0.15 0.26 0.51
PR2 0.40 1.13 1.23
B AMMOS MMFF94s Tff
raloxifene 2.12 2.39 1.51
FDI 1.88 1.90 1.52
thymidine 1.03 1.01 1.17
PR2 1.69 1.68 1.57
The minimization with AMMOS is performed with 2×500 iterations 
and sp4 force field.
Structural refinement of four small molecules with AMMOS  (magenta), MMFF94s (cyan) and Tff (yellow) Figure 2
Structural refinement of four small molecules with 
AMMOS (magenta), MMFF94s (cyan) and Tff (yel-
low). The minimized structures are superimposed on the 
corresponding X-ray structures (all atom colored). 
Raloxifene (A), FDI (B), thymidine (C) and PR2 (D).BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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least as implemented in the AMMP package. This is of
interest since, when the derivatives of the energy function
are high, it is usually accepted that steepest descents is the
most appropriate minimizer. Overall, these results and
tests demonstrate the efficiency of AMMOS in the struc-
tural refinement of a compound collection.
II. Energy minimization of protein-ligand complexes with AMMOS
Generation of docked protein-ligand complexes
Prior to the minimization step carried out with the
AMMOS procedure, the protein-ligand complexes were
generated using a two-step docking protocol (see Meth-
ods). The decoy library contains 37,970 drug-like mole-
cules and two protein targets were used for the VLS
experiments. The 37,970 compounds were docked/scored
on each protein target, NA and ER, employing first rigid
body docking performed with our MS-DOCK protocol
[47] and next flexible docking (from the ligand side) with
DOCK6. The top ~30% best scored molecules were
selected after the rigid docking step and 6 known actives
for ER out of 10 were found. In the case of NA, we decided
to select about 50% of the best-scored molecules after the
rigid docking, and among these, 6 actives out of 10 were
present. In our previous study [47], we demonstrated that
for large ligands filling well the binding pocket (which is
the case of ER) selecting the top 30% of the database after
shape-complementarity filtering by rigid docking gives a
sufficient enrichment for a subsequent flexible docking
step. When relatively small ligands bind to a very open
and flat pocket (which is the case of NA), 50% of the top
ranked ligands after the first rigid docking step should be
selected for the subsequent flexible docking step. After
flexible docking, we disposed of two target-specific com-
pound libraries, each containing 12,000 compounds
(52,345 conformers) for ER and 22,000 compounds
(70,120 conformers) for NA. These two collections con-
taining pre-docked ligands in a multi-conformer state
were subsequently subjected to the AMMOS minimiza-
tion protocol.
Enrichment studies using AMMOS
We next investigated the impact of the minimization pro-
tocol and rescoring with AMMOS on enrichment. The
AMMOS runs were performed on ER and NA for the five
developed cases (see Figure 1 and the Methods for
details). Case 1 and 2 (full flexible receptor during the
minimization) were carried out only for the real actives to
reduce the calculation time. Calculations within the
framework of cases 3, 4 and 5, with a partial flexibility of
the protein within a 6Å sphere around the ligand (this is
a user defined parameter), were performed for the entire
pre-docked chemical library. As mentioned above, we
used conjugate gradient with the sp4  force field. We
decided to apply two cycles of 500 iterations in order to
have an acceptable compromise between level of minimi-
zation and calculation time.
Figure 4 illustrates the RMSD between the X-ray and
AMMOS minimized structures (applying all cases 1–5) for
6 ER and NA inhibitors retrieved after DOCK6 flexible
docking and saved in a multi-conformer state (up to 10
poses per ligand). Although ligands bound to proteins are
not always in the lowest-energy conformation [59], sev-
eral recent studies suggested that the bioactive ligand
structure should not deviate substantially from a low-
energy state [61]. Thus, the lowest-energy conformers are
also shown in Figure 4. As seen in this figure, for all shown
inhibitors but ER3, the best fitting conformers, with all
cases 1–5, show RMSD values with the experimental struc-
ture below 1.5 Å, highlighting further the performance of
AMMOS minimization [12]. Slightly better results were
obtained for ER when the whole receptor was involved in
the minimization (Fig. 4A) compared to the data in which
the binding pocket and/or the ligand alone were taken
into account (Fig. 4B). In the case of NA, important differ-
ences depending on the involved receptor level in the
minimization were not observed.
Further we validated the importance of using AMMOS as
a final step of a hierarchical VLS protocol. We used a two-
stage VLS protocol and a compound collection of 37,970
compounds to generate and select protein-ligand com-
plexes with satisfactory shape complementarity, thus
reducing the number of protein-ligand complexes to be
minimized. The final selected pre-docked protein-ligand
complexes for both protein targets containing 60% of the
real active compounds were subjected to energy minimi-
zation with AMMOS. Figure 5 shows the enrichment
graphs for the two targets before and after application of
the AMMOS minimization protocol. Enrichments for the
ER inhibitors (Figure 5A) when employing cases 3 (red)
and 4 (magenta) are better than with the case 5 (green). In
both cases 3 and 4, AMMOS retrieved 50% of the inhibi-
tors in the top 3% (1200 compounds) of the entire data-
base.
NA is known as a "difficult" protein target because its
binding pocket is open and flat and thus challenging for
docking-scoring methods. Despite these difficulties,
results obtained after the three-minimization cases with
AMMOS (Figure 5B) are reasonable. Again, 50% of the
inhibitors are found in less than 10% of the proceeded
database. It is interesting to note that when the protein
was kept rigid (case 5, green), slightly better results for NA
were achieved after AMMOS minimization. The above
results suggest that AMMOS performs well and its use can
help to improve enrichment in multi-step SBVLS proto-
cols.BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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RMSD (Å) between the AMMOS minimized and X-ray structures for the inhibitors retrieved for the ER and NA targets Figure 4
RMSD (Å) between the AMMOS minimized and X-ray structures for the inhibitors retrieved for the ER and 
NA targets. A. Each point represents a single conformer minimized with case 1 (black), case 2 (grey); Triangles refer to the 
conformers with lowest energy after AMMOS minimization; B. All conformers are represented by points, with respectively 
black for case 3, grey for case 4 and white for case 5. Triangles refer to the conformers with lowest energy after AMMOS min-
imization.
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Discussion
Optimization of existing SBVLS tools and development of
open source packages are of crucial importance to assist
drug discovery projects. In this work, we developed a new
software tool named AMMOS that refines the 3D structure
of compounds present in a compound collection, opti-
mizes the binding poses of docked ligands through MM
minimization, and rescores these protein-ligand com-
plexes. The open source package AMMOS wraps and
enhances the functionality of the MM simulation program
AMMP, facilitating its use for in silico screening. Numer-
ous algorithms and protocols can be used to perform
SBVLS experiments but in most cases, the receptor struc-
ture remains rigid during the docking/scoring procedure.
Similarly, compounds obtained from chemical vendors
are in 2D and their 3D structures have to be generated.
Several tools can perform this task but rarely the com-
pound 3D structures are refined prior to docking while it
is known that this can be critical for positioning and obvi-
ously scoring [19]. Further and in order to speed-up the
SBVLS process, hierarchical protocols have been devel-
oped. These ones can include a relatively crude initial
shape complementarity filtering step (e.g., rigid docking
with compounds present in multi-conformer states) fol-
lowed by flexible docking with flexibility allowed only for
the ligands. In several situations, it could be beneficial for
users to have a tool allowing for partial to fully flexible
energy minimization of the protein-ligand complexes,
either to help ranking or to optimize the docked poses
prior to selecting a list of molecules for experimental
assay. AMMOS can be applied in these situations as illus-
trated below.
Structural refinement of the compound collections with 
AMMOS
Some recent reports suggest that it could be beneficial to
minimize the 3D structure of the small molecules before
performing docking/scoring computation [18,19,59]. The
question is indeed complex because it is widely accepted
that ligands do not necessarily adopt their lowest poten-
tial energy conformations when bound to a protein. In
fact, ligand energies of bioactive conformations have been
estimated to be around 5 kcal/mol above the lowest con-
formation energy of the same compound in solution [59].
Further, a recent study carried out on 100 protein-bound
ligand crystal structures shows that the ligand conforma-
tions are nearly identical to their local minimum confor-
mations obtained from normal mode analysis-monitored
energy minimization [18]. All these studies demonstrate
that the ligands bind to proteins in a relatively low energy
state, suggesting that highly strained energy input ligand
conformations should not be appropriate for docking
procedure, keeping in mind that many docking algo-
rithms alter the pose of their input ligands only through
translation, rotation, and some dihedral angle variations
at rotatable bonds. Minimizing compound collections
prior docking experiments was demonstrated to improve
both docking and scoring with Surflex [19]. Our prelimi-
nary tests involving docking (with DOCK6) of ER inhibi-
tors initially minimized with AMMOS (see Additional File
2) indeed suggest that minimizing small molecules prior
to docking can improve at least the docking accuracy.
Thus, as seen in the result section, AMMOS is able to auto-
matically energy minimize a large compound collection.
The resulting compounds have less strain energy but
remain close from experimental structures and display
similar structural features as compounds energy mini-
mized with two other well-known force fields.
Enrichment graphs for ER (A) and NA (B) inhibitors after  AMMOS minimization and rescoring Figure 5
Enrichment graphs for ER (A) and NA (B) inhibitors 
after AMMOS minimization and rescoring. The y-axis 
is the % of retrieved actives versus the percentage of the 
database screened (x-axis): enrichment results after flexible 
docking step (blue); enrichment results after re-scoring 
employing AMMOS minimization: case 3 (red), all protein 
atoms inside a sphere around the ligand can move; case 4 
(magenta), all side chain protein atoms inside a sphere 
around the ligand can move; case 5 (green), the whole pro-
tein is rigid.
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Refinement of protein-ligand complexes and re-scoring 
with AMMOS
It is important to note that, at present, it is generally
accepted that MM methods are not well-suited for a large
scale VLS computations because they are slowing down
the calculations and since it is unclear whether or not
energy minimization with current force fields could help
in the ranking process [62] (i.e., does MM minimization
optimize the poses, does computed interaction energy
after energy minimization is beneficial to ranking). Some
of these questions start to be addressed as for instance sev-
eral recent studies suggest that post-docking energy mini-
mization can significantly improve enrichment for some
protein targets [24-26]. It is expected that rescoring after
MM minimization cannot help when the ligand is
wrongly positioned in the binding cavity, however, when
the pose generated by a docking engine is near the exper-
imental conformation, energy minimization seems to be
able to optimize locally the structure of the complexes,
and in this case, the computed energy values (based on
traditional force fields or via other scoring approaches) of
the minimized structures can be effective at improving
ranking and enrichment [24].
In the present study, we provide users with the AMMOS
package that refines the structure of pre-docked ligand-
protein complexes. To illustrate our method, we applied a
two-step docking-scoring VLS protocol (i.e., rigid body
docking with MS-DOCK and subsequent ligand flexible
docking with DOCK6) on two protein targets, ER and NA.
Then, we minimized the 10 best poses obtained with
DOCK6 with AMMOS and re-scored each pose. Enrich-
ment curves were obtained with different levels of allowed
receptor energy minimization (Figure 5). As seen,
employing fully flexible minimization in the binding site
can considerably improve enrichment as it was observed
in the case of ER with 50% of the inhibitors retrieved in
the top 3% of the entire database. Thus, users can select
different protocols depending on the projects and needs
(e.g., consider small local flexibility in the binding site
area). In terms of efficiency, enrichments obtained by
AMMOS are similar to those seen by other tools such as
PLOP [26]. Indeed, after AMMOS rescoring, we found
40% of the NA inhibitors and 60% of the ER active com-
pounds in the top 5% of the compound libraries (2000
compounds).
Although the post-docking MM minimization of docked
poses can improve the binding modes and the scoring in
VLS, it has been also observed that relaxing the protein-
ligand complexes for some proteins can worsen the final
enrichment although the binding modes are improved.
For instance the MM scoring method PLOP [25] involving
a generalized Born solvent model has been shown to
improve the overall enrichment only for five out of ten
tested protein targets. In average, for these ten targets, bet-
ter enrichment factors were obtained in the top 0.5% of
the proceeded database, however only 10–30% of the
inhibitors were retrieved in this limited range. Further
similar rescoring via the molecular mechanics-generalized
Born surface area (MM-GBSA) method [63] with relaxa-
tion of the protein-ligand complexes by MM minimiza-
tion with PLOS or short molecular dynamics (MD) with
AMBER-DOCK on three simple ligand binding cavities
helped to discriminate between several active inhibitors
and experimentally proven decoy molecules. Here again,
the obtained enrichment factors were lower than those
found by docking alone before relaxation and rescoring
with MM-GBSA. In that study the authors proposed that
ligands too large to be accommodated after docking could
indeed fit after relaxation of the binding site. In addition,
some imperfections in the balance between polar interac-
tions and solvation penalties can be present in the MM-
GBSA methodology.
Along the same line of reasoning, in our study and in the
case of ER where large ligands fill well the binding site
(with the ratio Volume of the ligand/Volume of the
pocket of 0.95) allowing receptor relaxation with AMMOS
(case 3 and case 4) led to considerable improvement of the
enrichment factors (see Fig. 5A). On the other hand, we
did not obtain better enrichment after AMMOS in the case
of NA (Fig. 5B). Also, our additional tests with AMMOS
applied on a third protein target, thymidine kinase, did
not improve the final enrichment, particularly with cases 3
and 4 when local receptor flexibility was allowed (data
not shown). It seems, that for some binding pockets and
ligands, allowing post-docking relaxation of the protein-
ligand complexes may worsen the enrichment, thereby
increasing the number of false positives, as we observed
not only in our investigation of NA and thymidine kinase
but also in other studies [25,63]. For NA and thymidine
kinase, the ligands do not fill well the binding sites (with
a Volume of the ligand/Volume of the pocket ratio of 0.44
and 0.45, respectively). Thus, it can be speculated that for
large pockets accepting relatively small ligands, authoriz-
ing flexibility around the binding site could damage the
final enrichment.
In terms of speed, AMMOS can perform full atom minimi-
zation of the binding site area in about ~30–45 sec/ligand
conformer with the default parameters. The protocol pro-
vided offer a reasonable compromise between speed and
accuracy but the users can reduce the number of iterations
and speed-up the calculations, depending on the aims of
the projects. In addition, multiple poses optimized with
AMMOS can be subsequently re-ranked by employing
other scoring functions or consensus scoring [2,16].BMC Bioinformatics 2008, 9:438 http://www.biomedcentral.com/1471-2105/9/438
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Conclusion
An efficient MM minimization engine called AMMOS that
makes use of the AMMP simulation package has been pre-
sented. The fully automatic open-source package AMMOS
can perform energy minimization of a large compound
collection prior to docking and can also refine pre-docked
ligands in the context of a protein structure. AMMOS exe-
cutes efficient and fast minimization procedures and can
thus be employed over a large number of protein-ligand
complexes. The users can select the energy minimization
protocol depending on the projects and, for instance, fix
the protein atoms or allow full flexible minimization of
both, the ligand and the receptor. Several initial tests were
carried out in order to assess AMMOS. We applied our
package on two protein targets, ER and NA, which have
very different binding site properties. Results shows that
AMMOS performs well on large pre-docked compound
collections, retrieving most of the active compounds in
the top 3% to 5% of the entire database. Although MS-
DOCK and DOCK6 were used in this work, users can
apply other docking programs to dock a compound
library.
The present version of AMMOS does not take into consid-
eration possible solvation effects, yet, a few water mole-
cules could be treated by the minimization procedure.
However, in such a situation, we do not provide a fully
automatic procedure and the users should prepare the
proper input files. Automated protocol will be imple-
mented in a future release of AMMOS to treat solvation
and water molecules. The full AMMOS package is freely
available and should be valuable to research groups
involved in drug discovery and chemical biology projects.
Availability and requirements
AMMOS is written in C and python and runs on Linux
platforms. It is also operational on MacOSX system.
Detailed installation instructions are provided in the soft-
ware package. The source code of AMMOS is freely availa-
ble under the terms and conditions of the GNU Public
License from http://www.vls3d.com/.
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